Author:
Zhang Yue,Zeng Miao,Zhang Xiaolu,Yu Qun,Wang Luming,Zeng Wenyun,Wang Yijing,Suo Yanrong,Jiang Xijuan
Funder
National Natural Science Foundation of China
Subject
Drug Discovery,Pharmacology
Reference74 articles.
1. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE;Bradley;The Journal of clinical investigation,2007
2. Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ;Chen;Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2021
3. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding;Cheung;Biochem. J.,2000
4. Mechanisms of foam cell formation in atherosclerosis;Chistiakov;Journal of molecular medicine (Berlin, Germany),2017
5. AMPK as a therapeutic target for treating metabolic diseases;Day;Trends in endocrinology and metabolism: TEM,2017